The VariantPlex Pan Solid Tumor panel is a targeted next-generation sequencing (NGS) assay that simultaneously detects and characterizes copy number variations (CNVs), single-nucleotide variants (SNVs), insertions and deletions (indels), and microsatellite instability (MSI) status in 185 cancer-implicated genes, including non-small cell lung cancer, colorectal cancer, breast cancer, bladder cancer, gastric cancer, pancreatic cancer, prostate cancer, ovarian and uterine cancers, CNS cancers, cholangiocarcinoma and melanoma. Representing our most comprehensive DNA-based assay for solid tumor research, this newly expanded panel was thoughtfully designed based on guidelines, literature, and customer input, and offers sensitive variant detection even with low sample input.